Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

cardiovascular · Mechanism Report

Do low large HDL particles and small HDL size indicate weaker HDL maturation despite optimal HDL-C?

Low large HDL particles and small HDL size can indicate weaker HDL maturation and reduced reverse-cholesterol-transport resilience even when HDL-C is optimal.

PlausibleJuly 26, 202613 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Low large HDL particles and small HDL size can reflect weaker HDL maturation and reverse-cholesterol-transport resilience even when HDL cholesterol concentration is optimal.

laying out figure…
2 of 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says HDL-C concentration can look normal while HDL particle size and composition still reflect a functional weakness. The mechanism frames this as impaired LCAT-driven remodeling, with fewer mature large HDL particles and less robust cholesterol transport clearance.

Verified conclusion

Standard lipid panels measure high-density lipoprotein cholesterol (HDL-C) mass, which can obscure critical functional deficiencies in the HDL network. Optimal HDL-C concentration does not guarantee effective cardiovascular protection if particle maturation and clearance pathways are compromised.

Mechanisms of HDL maturation

  • LCAT-driven remodeling: HDL maturation is an active biochemical process driven by lecithin:cholesterol acyltransferase (LCAT). LCAT esterifies free cholesterol on small, discoidal pre-β HDL, converting them into larger, spherical α-HDL particles containing hydrophobic cholesteryl ester cores.
  • Maturation failure: A deficiency in large HDL particles alongside a predominantly small HDL size directly reflects weaker or incomplete maturation. In LCAT deficiency states, this failure to esterify cholesterol results in an accumulation of small, immature particles and a distinct lack of mature α-HDL.

Reverse cholesterol transport resilience

  • Efflux pathway disconnect: Small, lipid-poor HDL particles successfully initiate reverse cholesterol transport (RCT) via ABCA1-mediated macrophage efflux. However, complete RCT resilience requires downstream maturation into larger α-HDL to facilitate final cholesterol clearance through ABCG1 and scavenger receptor B1 (SR-B1) pathways.
  • Loss of concentration gradient: Decreased LCAT activity impairs RCT by failing to maintain the low concentration gradient of unesterified cholesterol. Without this gradient, continuous cellular efflux is disrupted, promoting cholesterol re-uptake by peripheral cells.

Bottom line

  • A depletion of large HDL particles and a predominantly small HDL size signify impaired HDL maturation and compromised reverse-cholesterol-transport resilience, exposing functional deficits that remain hidden under standard, optimal HDL-C measurements.

References

  1. 32854 — jstage.jst.go.jp ↗
  2. Role of apolipoproteins, ABCA1 and LCAT in the biogenesis ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  3. Structural analysis of lecithin:cholesterol acyltransferase ... — nature.com ↗
  4. HDL and Reverse Cholesterol Transport | Circulation Research — ahajournals.org ↗
  5. High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis — pmc.ncbi.nlm.nih.gov ↗
  6. Role of LCAT in HDL remodeling — pubmed.ncbi.nlm.nih.gov ↗
  7. Lecithin:cholesterol acyltransferase: old friend or foe in ... — pubmed.ncbi.nlm.nih.gov ↗
  8. rHDL modeling and the anchoring mechanism of LCAT activation — ncbi.nlm.nih.gov ↗
  9. The origin and metabolism of a nascent pre-β high density lipoprotein involved in cellular cholesterol efflux. — ojs.ptbioch.edu.pl ↗
  10. The origin and metabolism of a nascent pre-β high density ... — pubmed.ncbi.nlm.nih.gov ↗
  11. High-density lipoprotein heterogeneity and function in reverse cholesterol transport — pmc.ncbi.nlm.nih.gov ↗
  12. HDL Particle Size and Functional Heterogeneity. — pmc.ncbi.nlm.nih.gov ↗
  13. High Density Lipoprotein Cholesterol Efflux Capacity and ... — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesAre F2-isoprostanes biomarkers of lipid peroxidation and does oxidized LDL contribute to atherosclerosis?→Plausible10 sourcesDo hs-CRP, Lp-PLA2, and myeloperoxidase reflect different cardiovascular risk signals?→